1. Identification of a potent xanthine oxidase inhibitor from oxidation of caffeic acid
- Author
-
Yoshimi Shingai, Miyuki Inai, Chizuru Takahashi, Akiko Masuda, Toshiya Masuda, Yukari Miura, and Sari Honda
- Subjects
Xanthine Oxidase ,Antioxidant ,medicine.drug_class ,Allopurinol ,Iron ,medicine.medical_treatment ,Chemical structure ,Biochemistry ,Antioxidants ,chemistry.chemical_compound ,Caffeic Acids ,Phenols ,Physiology (medical) ,medicine ,Caffeic acid ,Organic chemistry ,Enzyme Inhibitors ,Xanthine oxidase ,IC50 ,Xanthine oxidase inhibitor ,Molecular Structure ,chemistry ,Reactive Oxygen Species ,Oxidation-Reduction ,medicine.drug - Abstract
Inhibitory activity of Fe-ion-catalyzed radical oxidation products from 22 types of phenolic compounds toward xanthine oxidase (XO) was investigated. Phenols are readily oxidizable compounds in nature and, thus, showed potent antioxidant activities. Among the phenols screened in this study, noticeable activity was observed in the oxidation product of caffeic acid, whereas almost no XO-inhibitory activity of caffeic acid was observed. Assay-guided purification of the oxidation product of caffeic acid afforded a highly potent XO inhibitor, with an IC50 value that was calculated to be 60 nmol L(-1), which indicated XO-inhibitory activity much stronger than that of allopurinol (IC50 = 1 μmol L(-1)), a potent XO inhibitor and excellent medicine for the treatment of gout. The chemical structure of this new XO inhibitor was investigated by one- and two-dimensional NMR and HR-ESI-MS analyses, and the unique tetracyclic structure was confirmed by synthesis starting from commercially available 1,2,4-trimethoxybenzene and 3,4-dimethoxylbenzoyl chloride.
- Published
- 2014
- Full Text
- View/download PDF